This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Cancer
and you are
between 20 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about how interleukin-2, interleukin-12, and GM-CSF delivered in microspheres increase the body's ability to kill tumor cells. PURPOSE: This laboratory study is looking at microsphere-delivered cytokines to see if they increase tumor response in lymphocytes from patients with head and neck cancer.

Provided treatments

  • Biological: aldesleukin
  • Biological: recombinant interleukin-12
  • Biological: sargramostim
  • Other: immunologic technique
  • Procedure: biopsy
Tris trial is registered with FDA with number: NCT00899821. The sponsor of the trial is New York University School of Medicine and it is looking for 0 volunteers for the current phase.
Official trial title:
Head And Neck Cancer Immunotherapy Using Biodegradable Microspheres